Professor Ichizo NishinoThe World Federation of Neurology (WFN) is pleased to announce the appointment of Prof. Ichizo Nishino, MD, PhD, as the next Editor-in-Chief of the Journal of the Neurological Sciences (JNS), the official scientific journal of the WFN.

Prof. Nishino brings decades of internationally recognised expertise in neuromuscular research, molecular diagnostics, and therapeutic developments for muscle diseases. He currently serves as Director of the Department of Neuromuscular Research at the National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP) in Tokyo, Japan.

In addition to his clinical and research accomplishments, Prof. Nishino holds key leadership roles across the global neurological community. He serves as President of the Asian Oceanian Myology Center (AOMC), Treasurer of the World Muscle Society (WMS), and is an active member of the WFN Education Committee. His long-standing involvement with JNS includes serving as a dedicated member of its editorial board since 2013.

"I am honored to take on this role and look forward to working with my colleagues at the WFN," said Prof. Nishino regarding his appointment.

Prof. Nishino will officially succeed Prof. John D. England, MD on January 1, 2027, who has served as Editor-in-Chief for 13 years (2013–2026). The WFN expresses its deepest gratitude to Dr. England for his extraordinary leadership, dedication, and significant contributions to advancing the scope, quality, and international impact factor of the journal during his long-standing tenure.   

Under Prof. Nishino’s guidance, the Journal of the Neurological Sciences will build upon this strong foundation, continuing its commitment to publishing high-impact clinical and basic research across all areas of neurology, including brain health.

About the Journal of the Neurological Sciences The Journal of the Neurological Sciences is the official journal of the World Federation of Neurology. It publishes original clinical research and other clinically-relevant articles applying directly to neurological disorders, serving an international audience of clinicians, researchers, and academic neurologists.